JBM (Healthcare) Limited
HKSE: 2161.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yat Wai Wong
- Employees
- 279
- Headquarters
- Kwun Tong, Hong Kong SAR China
- IPO year
- 2021
- Market cap
- HK$2.0B
- Website
- https://www.jbmhealthcare.com.hk
Loading 2161…
Loading profile data…Frequently asked questions about 2161
What does JBM (Healthcare) Limited (2161.HK) do?
JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and phar...
Where does 2161.HK trade?
JBM (Healthcare) Limited (2161.HK) trades on the Hong Kong Stock Exchange.
What sector is 2161.HK in?
JBM (Healthcare) Limited (2161.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of JBM (Healthcare) Limited?
Yat Wai Wong is the chief executive officer of JBM (Healthcare) Limited (2161.HK).
Where is JBM (Healthcare) Limited headquartered?
JBM (Healthcare) Limited is headquartered in Hong Kong SAR China.
Does 2161.HK pay a dividend?
Yes — JBM (Healthcare) Limited (2161.HK) paid a trailing twelve-month dividend of HKD 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2161.HK go public?
JBM (Healthcare) Limited (2161.HK) completed its initial public offering in 2021.